Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China flag China · Delayed Price · Currency is CNY
12.47
-0.20 (-1.58%)
Nov 13, 2026, 3:04 PM CST

SHE:002393 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,2151,5381,6391,9891,7931,652
Short-Term Investments
--156.9470.72--
Trading Asset Securities
1,0651,020573.36160.54200.32-
Cash & Short-Term Investments
2,2802,5582,3692,2201,9941,652
Cash Growth
11.84%7.97%6.71%11.37%20.69%5.80%
Accounts Receivable
461.89408.91427.03312.51387.99414
Other Receivables
79.72126.43.214.410.877.43
Receivables
541.61535.32430.24316.91398.86421.43
Inventory
236.43215.11224.37176.28199.15228.78
Other Current Assets
31.5421.0735.81105.1133.7854.32
Total Current Assets
3,0903,3303,0602,8192,6252,356
Property, Plant & Equipment
937.1967.81,020976.481,0301,137
Long-Term Investments
881.62932.192.77194.051,4311,500
Goodwill
70.0870.3670.72---
Other Intangible Assets
137.16141.35184.06124.86135.49144.22
Long-Term Deferred Tax Assets
74.4873.6743.839.4733.7116.31
Long-Term Deferred Charges
3.43.950.92---
Other Long-Term Assets
123.7265.481,3131,62735.9837.49
Total Assets
5,3175,5845,7865,7815,2915,191

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
103.19130.57135.8490.36146.3890.49
Accrued Expenses
53.78290.29290.83251.39297.23228.97
Short-Term Debt
-37.9639.7928.639.2928.14
Current Portion of Leases
3.012.992.840.870.420.4
Current Income Taxes Payable
42.7111.5711.7214.612.225.79
Current Unearned Revenue
16.8823.443414.9430.5411.29
Other Current Liabilities
414.57264.9231.5225.5203.9187.4
Total Current Liabilities
634.15761.73746.53626.27729.98552.47
Long-Term Leases
2.484.548.383.955.376.2
Long-Term Unearned Revenue
34.6932.9728.5127.9331.8331.68
Pension & Post-Retirement Benefits
10.3410.341111.3511.2811.31
Long-Term Deferred Tax Liabilities
106.74107.4181.01204.09162.04178.77
Other Long-Term Liabilities
6.016.8710.113.581.16-
Total Liabilities
794.41923.86985.54877.17941.66780.42

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
308.29257.59257.9184.28183.99182.45
Additional Paid-In Capital
1,5731,6221,6521,7211,7121,692
Retained Earnings
2,1152,2691,9421,8571,5511,512
Treasury Stock
-73.99-85.77-61.05-24.09-21.01-
Comprehensive Income & Other
566.22565.19978.461,165924.041,025
Total Common Equity
4,4894,6284,7704,9034,3494,411
Minority Interest
33.4932.4930.06---
Shareholders' Equity
4,5234,6614,8004,9034,3494,411
Total Liabilities & Equity
5,3175,5845,7865,7815,2915,191

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
5.4945.4951.0133.4245.0834.74
Net Cash (Debt)
2,2752,5132,3182,1871,9491,617
Net Cash Growth
13.46%8.39%6.01%12.23%20.49%4.86%
Net Cash Per Share
7.298.157.547.056.325.28
Filing Date Shares Outstanding
315.51308.26307.52312.97309.11306.52
Total Common Shares Outstanding
315.51307.38307.52312.97309.11306.52
Working Capital
2,4552,5682,3132,1921,8951,804
Book Value Per Share
14.2315.0615.5115.6714.0714.39
Tangible Book Value
4,2824,4164,5154,7794,2144,266
Tangible Book Value Per Share
13.5714.3714.6815.2713.6313.92
Buildings
-972.8989.32930.62950.07941.9
Machinery
-568.49552.53507.9517.78496.86
Construction In Progress
-8.317.617.0412.79154.51